Received for publication July 9, 1958 THE host response to neoplasia may be quite variable depending on the parameter observed, the strain or species of animal studied, nutritional state of the animal, and other factors. Of the various parameters considered, the one which stands out as the most nearly universal host response to early neoplasia is the depression in hepatic catalase activity. This subject has been reviewed by Greenstein (1954) . The enzyme delta-aminolevulinic acid dehydrase may show a response similar to that of catalase (Tschudy and Collins, 1957) . The underlying mechanism of this catalase response has been studied extensively and has led to a consideration of the following factors: (1) That the tumor elaborates a " toxohormone " which depresses catalase activity (Nakahara and Fukuoka, 1948; Fukuoka and Nakahara, 1951; Greenfield and Meister, 1951; and Ceriotti and Spandrio, 1955) ; (2) that the depression may be related to the presence of excess sulphydryl groups or ascorbic acid which could give rise to an inactive catalase-H202 complex (Alexander, 1957) ; and (3) that the effect of a neoplastic growth. may be similar to that produced by administration of 3-amino-1,2,4-triazole (Heim, Appleman and Pyfrom, 1955; Heim, Appleman and Pyfrom, 1956; Sugimura, 1956; and Feinstein, 1958) . This question is still unresolved.
Since the depressed hepatic catalase activity in tumor-bearing animals has been established beyond doubt, it seemed worth while to investigate an enzyme system whose function might be related in some way to the level of catalase activity. With this in mind we undertook the study of myeloperoxidase (MPO) in tumor-bearing mice. Myeloperoxidase, formerly called verdoperoxidase and studied in detail by Agner (1941) , is an iron-porphyrin-containing enzyme which utilizes hydrogen peroxide as a substrate, the enzyme-substrate complex then having the capacity to oxidize donor molecules such as aromatic amines, phenols, and natural compounds such as epinephrine, ascorbic acid, etc. (Theorell, 1951) . Since this enzyme has thus far been demonstrated only in cells of the myeloid series, this study was carried out on bone marrow tissue.
MATERIALS AND METHODS
In order to develop quantitative data on a tissue such as mouse bone marrow, we adopted the procedure of homogenizing the whole, cleaned mouse femur in a Virtis " 23 " homogenizer. The femur was scraped clean of all adherent tissue so as not to vitiate subsequent protein determinations performed on the extracts. Some control observations on bone marrow tissue taken from rat femur gave figures of the same order of magnitude as that obtained on the whole homo-genized femur, so it was assumed that components of the bony matrix did not significantly alter the activity of myeloperoxidase (MPO).
As reported by Bancroft and Elliott (1934) , and earlier workers, we found that extraction of tissue with phosphate buffer at pH 7-0 removed approximately 50 per cent of the total MPO activity which could be detected. Following a procedure suggested by Wattiaux and de Duve (1956) , and explored also by Adams and Burgess (1957) , we tried tissue extractions with phosphate buffer containing 041 per cent Triton X100 and obtained activity levels substantially greater than that obtained without Triton, approaching 100 per cent of the detectable enzyme activity. A word of caution should be mentioned at this point. In some extracts subjected to freezing at -700 C., and thawing, additional MPG activity could be detected. It is presumed that some finely divided material was present in the extract and that this underwent structural alteration liberating the additional activity (see below). We have been unable to elicit this effect consistently. Although our standard procedure now allows the low temperature storage of tissue, but not the extract, and involves treatment of the homogenate with n-butanol followed by assay ofthe extract within a few hours, it was considered desirable to record some of our observations on stored extracts, prepared with and without n-butanol. These observations are discussed below.
Since phosphate buffer of low ionic strength is generally used in the assay reaction mixture, and phosphates have been reported to weaken the peroxidase reaction with guaiacol (Ostrovskaja, 1950) , it seemed advisable to select a different buffer, and one which would be less influenced by the composition of the sample. For these reasons tris buffer at pH 7 0 was tested and found to give results comparable with phosphate buffer.
Increasing the ionic strength of the guaiacol reagent with sodium chloride increased the measured activity. With a final sodium chloride concentration in the reagent of 0-85 per cent, the activity was 34 per cent greater than at 0-45 per cent. With 125 per cent NaCl concentration, the activity was only 10 per cent greater than at 0*85 per cent.
Treatment of the homogenate with n-butanol for 5 minutes served to break the emulsion which formed during homogenization, and also increased the activity by 5-10 per cent. It was found, however, that when extracts were prepared with n-butanol and stored at -700 C. protein denaturation occurred more rapidly than when n-butanol was not used. As noted below, extracts prepared with n-butanol and stored at -700 C. seemed to liberate more activity, if not stored too long, and to suffer more rapid denaturation when storage was prolonged.
Reagents
Stock tris solution: 0-2 M tris-(hydroxymethyl)-aminomethane (Sigma 7-9). Tris buffer, 0.02 M: 100 ml. of 0.2 M tris and 94 ml. 
Procedure
The mouse is sacrificed with ether, the hind limbs are promptly disarticulated and the femurs removed and stored at -150 C. for at least 10 minutes. The frozen femurs are then carefully trimmed and scraped free of all adherent tissue, transferred to small test tubes and stored at -700 C. until taken for assay. In control studies no significant differences in MPO activity were observed in femurs stored up to 17 days. Longer storage periods were not tested. The frozen femur is cut with scissors into the stainless steel Virtis homogenizing vessel which contains 0-5 ml. of tris-Triton, and is kept cold with ice cubes. Homogenization is carried out at 13,000 r.p.m. for 2 minutes. While the shaft is revolving slowly, 25 ,ul. of n-butanol (5 per cent) are added gradually. The emulsion is readily broken and stirring is continued for 5 minutes. The cold homogenate is transferred to a cold 1 ml. microcentrifuge tube, the steel vessel is rinsed with 0 3 ml. and 0-2 ml. of tris-Triton solution, and the rinsings are added to the homogenate and mixed. The tubes are then centrifuged in the cold (40 C.) for 3 minutes at 10,000 r.p.m. (5200 G.). The supernatant fluid is then decanted and kept in an ice-bath until assayed. The assay is performed at three levels (25-100 ,ul.) essentially as described by 0*22 
Experimental tumors
Bone marrow MPO levels were measured against time after inoculation or implantation with three different types of tumor, the Ehrlich ascites carcinoma, C-1498 myelogenous leukaemia, and Sarcoma 180. Twenty-gram mice were employed in all cases, using the C57 Bl mice for the C-1498 implants and Swiss Webster mice for the other two tumors. The Ehrlich ascites carcinoma was inoculated, intraperitoneally, as 0*1 ml. of a 7-day growth. This inoculum was assumed to contain 107 cells. The C-1498 and S-180 tumors were implanted as tumor bits in the right axillary region with the conventional trocar technique. Control mice for the Ehrlich ascites experiments received intraperitoneal injections of normal saline; controls in the C-1498 experiment were untreated; and controls in the S-180 experiment were subjected to sham implants by trocar.
RESULTS

Ehrlich ascites carcinoma
In a preliminary experiment involving three control mice and three inoculated with Ehrlich ascites carcinoma, one experimental animal and its control were sacrificed and assayed for MPO on days 2, 6, and 8 after inoculation. Extracts of the left and right femurs of each animal were prepared without n-butanol and assayed separately without storage. The MPO specific activity showed a linear increase against time amounting to 7*7 per cent per day. The same experiment was repeated using four control and six experimental mice (Expt. EMA-J). The latter were sacrificed in groups of two on days, 1, 3, and 6 after inoculation and each femur was assayed separately. These specific activity values were of the same magnitude as in the preliminary experiment and are shown in Table I . EMA-JI) and in this case the experimental animals were sacrificed on the first 6 consecutive days after inoculation, two on each day. Controls were sacrificed on days 0, 2, 4, and 6. In addition, the bone marrow extracts from the right and left femur of each mouse were prepared with n-butanol, pooled, and stored at -700 C. for 2 weeks before assay. These results are shown in Table II . Here one observes that both the control and experimental specific activity values are substantially higher than those obtained in the previous experiment. Furthermore, the experimental levels are appreciably higher than the controls, + 5845
per cent, and this increase appears to have occurred abruptly. This was the only experiment which yielded such high values, and the only one in which the extracts prepared with n-butanol were stored before assay. As mentioned above, these results indicate that storage of extracts at -700 C. can liberate additional activity. However, preliminary tests of this observation gave inconsistent results. One gains the impression that liberation of activity and destruction of enzyme under these conditions are occurring simultaneously and at different rates. A comparison of this experiment with the preceding one suggests that there may be two forms of myeloperoxidase, that one form is readily extractable under the conditions described above, and that the other form becomes progressively more extractable when a neoplastic process is present. The higher values for both the control and experimental extracts of experiment EMA-II are probably due to the presence of n-butanol in the extract plus storage at -700 C. These condi- Sarcoma 180 Nineteen mice were studied in this experiment, the seven control mice receiving sham implants by trocar. The extracts were prepared with n-butanol, kept in an ice-bath, and all were assayed within 3 hours after preparation. Extracts of the right and left femur from each mouse were pooled after preparation. In Table  IV one will note that the specific activity of the day 0 control mice is higher than the day 2 and day 4 values. This is probably a stress response since the Since very little is known about the physiological function of animal peroxidases one can do little more than speculate on the significance of these findings. Neufeld et al. (1955) observed an increase in rat uterine peroxidase in response to estrogen administration and Lucas et al. (1955) were able to detect peroxidase activity in the Walker 256 rat carcinoma. They suggested that the enzyme might be involved in terminal respiration. The adaptive response of liver tryptophan peroxidase to elevated tryptophan levels (Knox and Mebler, 1950, 1951; Price and Dietrich, 1957) and of cytochrome-c peroxidase of Pseudomonas fluorescen8 to low oxygen tensions (Lenhoff and Kaplan, 1956) suggests that the increase in MPO activity in the presence of tumor may also be a type of adaptive response. Much more work is required to elucidate the true significance of these findings. SUMMARY 1. Evidence was presented showing a progressive increase in the level of myeloperoxidase activity in bone marrow extracts of mice bearing the Ehrlich ascites carcinoma, C-1498 myelogenous leukemia, and Sarcoma 180. The C57 Bl mouse which normally has a lower hepatic catalase level than the Swiss Webster mouse was found to have a higher bone marrow MPO level. In this strain the bone marrow MPO level of the tumor-bearing mouse dropped back to normal on day 6 after implantation.
2. The results of an experiment with the Ehrlich ascites carcinoma suggested the possibility of two forms of myeloperoxidase with one form being increased in the presence of neoplasia, and progressively liberated as the neoplastic growth develops.
